Anti-tumour necrosis factor treatment and pregnancy: The way is open

Clinical and Experimental Rheumatology

Volumn 30, Issue 3, 2012, Pages 453-

  Boulman, N ^a   Rimar, D ^a   Rozenbaum, M ^a   Slobodin, G ^b   Younis, S ^a   Rosner, I ^a  

^a Department of Rheumatology ^*  (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; CASE REPORT; CESAREAN SECTION; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERTILIZATION IN VITRO; HUMAN; LETTER; LEUKOPENIA; METACARPOPHALANGEAL JOINT; NULLIPARA; PREECLAMPSIA; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SYNOVITIS; LIVE BIRTH; NOTE; PREGNANCY COMPLICATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIVE BIRTH; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 84864750858     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. SCIOSCIA C, SCIOSCIA M, ANELLI MG, PRAINO E, BETTOCCHI S, LAPADULA G: Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis. Clin Exp Rheumatol 2011; 29: 93-95.
2. ROSNER I, HADDAD A, BOULMAN N et al.: Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford). 2007; 46: 1508.
3. OSTENSEN M, LOCKSHIN M, DORIA A et al.: Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford). 2008; 47 (Suppl. 3): iii28-31.
4. SKOMSVOLL JF, WALLENIUS M, KOKSVIK HS et al.: Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy, lactation. Nat Clin Pract Rheumatol 2007; 3: 156-164.
5. SCHNITZLER F, FIDDER H, FERRANTE M et al.: Outcome of pregnancy in women with inflammatory bowel disease treated with anti-tumor necrosis factor therapy. Inflamm Bowel Dis 2011; 17: 1846-1854.
6. VERSTAPPEN SM, KING Y, WATSON KD, SYMMONS DP, HYRICH KL, BSRBR CONTROL CENTRE CONSORTIUM, BSR BIOLOGICS REGISTER: Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011; 70: 823-826.